Polycystic Ovary Syndrome Clinical Trial
Official title:
Comparison of Probiotics, Metformin and Their Combination Therapy in Improving Symptoms of Polycystic Ovarian Syndrome.ĚŽ- A Randomized Clinical Trial
Polycystic ovary syndrome (PCOS) is a common gynecological state worldwide characterized by numerous small cysts in the ovaries mainly due to the imbalance of endocrine hormones in premenopausal women. Metformin is long being used for different symptoms of PCOS along with other medication. This study involves the assessment of different parameters of PCOS.
Polycystic ovary syndrome (PCOS) is a hormonal disorder affecting the women of reproductive
age. It is a heterogeneous health condition that affects 1 in every 10 women of childbearing
age. Women of all races and ethnicities are at risk for PCOS, but risk increases multiple
folds if the BMI is greater than 30kg/m2. The common signs and symptoms, the women usually
represent with are menstrual irregularities, hyperandrogenemia and multiple cysts in ovaries.
The exact cause of PCOS is still unknown but genetic and obesity is considered to be the most
common cause.
Metformin has been considered as the first line agent for the treatment of non-insulin
dependent diabetes mellitus and up till now it has been used as a first line drug for PCOS.
Despite its beneficial effects in PCOS it has several adverse effects. Moreover, patients
usually seek two or more drugs along with metformin to relieve maximum symptoms of PCOS like
for ovulation clomiphene citrate must be given etc. So there is a need of novel and
comprehensive agent that can prove to be effective in improving maximum symptoms of this
disease. Probiotics have received renewed attention in the 21st century through research
studies. World Health Organization's (WHO) 2001 defines probiotics as live micro-organisms
that, when administered in adequate amounts, confer a health benefit on the host. In recent
year it has shown tremendous promising effect in treatment of different diseases like
diarrhea, gingivitis and obesity etc with negligible side effects.
In this context the investigators are going to evaluate and compare the effects of
probiotics, metformin and their combination therapy in treatment of various symptoms of
PCOS.60 newly diagnosed PCOS patient will be assigned in the open label randomized clinical
trial. As mentioned above patients will be divided into three groups with 20 patients each.
In group 1, the dosage of metformin will be 500mg B.D and 2 gm of probiotic sachet O.D, the
second group will be given metformin 500mg B.D. and the third group will be 2mg of probiotics
B.D. It would be a follow-up study that would be conducted in Gynecology OPD of Tertiary Care
Hospital
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03142633 -
MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
|
||
Completed |
NCT06158932 -
A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Active, not recruiting |
NCT02500147 -
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
|
Phase 4 | |
Completed |
NCT04932070 -
Berberine and Polycystic Ovary Syndrome
|
N/A | |
Suspended |
NCT03652987 -
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
|
||
Completed |
NCT03480022 -
Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
|
Phase 3 | |
Active, not recruiting |
NCT03043924 -
Functional Study of the Hypothalamus in Magnetic Resonance Imaging (MRI) in Polycystic Ovary Syndrome (PCOS)
|
N/A | |
Completed |
NCT05246306 -
Aerobic Capacity and Physical Fitness Level of Adolescents With PCOS
|
||
Completed |
NCT05981742 -
Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS
|
Phase 2 | |
Completed |
NCT05702957 -
Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome
|
Phase 2/Phase 3 | |
Completed |
NCT05029492 -
Effect of Visceral Manipulation on PCOS
|
N/A | |
Not yet recruiting |
NCT02255578 -
Endobarrier Treatment in Women With PCOS
|
Phase 3 | |
Completed |
NCT02924025 -
Motivational Interviewing as an Intervention for PCOS
|
N/A | |
Not yet recruiting |
NCT00883259 -
Metformin and Gestational Diabetes in High-risk Patients: a RCTs
|
Phase 4 | |
Withdrawn |
NCT01638988 -
Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin
|
Phase 3 | |
Completed |
NCT02098668 -
Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON
|
N/A | |
Completed |
NCT01462864 -
Development of a Structured Education Programme for Women With Polycystic Ovary Syndrome
|
N/A | |
Recruiting |
NCT01431352 -
Letrozole Versus Chinese Herbal Medicine on Polycystic Ovary Syndrome (PCOS)
|
N/A | |
Completed |
NCT00989781 -
Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
|
N/A |